XML 15 R1.htm IDEA: XBRL DOCUMENT v3.24.3
Cover Page - USD ($)
$ in Billions
12 Months Ended
Dec. 31, 2023
Mar. 08, 2024
Jun. 30, 2023
Class of Stock [Line Items]      
Document Period End Date Dec. 31, 2023    
Document Type 10-K/A    
Document Annual Report true    
Document Transition Report false    
Entity File Number 1-44    
Entity Registrant Name ARCHER-DANIELS-MIDLAND CO    
City Area Code 312    
Local Phone Number 634-8100    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 41-0129150    
Entity Address, Address Line One 77 West Wacker Drive, Suite 4600    
Entity Address, City or Town Chicago,    
Entity Address, State or Province IL    
Entity Address, Postal Zip Code 60601    
Entity Well-known Seasoned Issuer Yes    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Large Accelerated Filer    
Entity Small Business false    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag true    
Entity Shell Company false    
Entity Public Float     $ 40.3
Entity Common Stock, Shares Outstanding   509,849,153  
Documents Incorporated by Reference
Portions of the Registrant’s definitive proxy statement relating to its 2024 annual meeting of stockholders, which was filed on April 10, 2024, are incorporated by reference into Part III of this Annual Report on Form 10-K/A where indicated.
   
Entity Central Index Key 0000007084    
Current Fiscal Year End Date --12-31    
Document Fiscal Year Focus 2023    
Document Fiscal Period Focus FY    
Amendment Flag true    
Auditor Name Ernst & Young LLP    
Auditor Location Saint Louis, Missouri    
Auditor Firm ID 42    
Document Financial Statement Error Correction [Flag] true    
Document Financial Statement Restatement Recovery Analysis [Flag] true    
Amendment Description Explanatory NoteArcher-Daniels-Midland Company (the “Company”) is filing this Amendment No. 1 on Form 10-K/A (this “Amendment”) to its Annual Report on Form 10‑K for the fiscal year ended December 31, 2023, which was originally filed with the United States Securities and Exchange Commission ("SEC") on March 12, 2024 (the “Form 10‑K”). In filing this Amendment, the Company is restating its previously issued audited consolidated financial statements as of December 31, 2023 and 2022 and for the years ended December 31, 2023, 2022 and 2021 (collectively, the “Affected Periods”) for the correction of certain segment-specific historical financial information as further described below.In addition, the Company intends to file an amendment to its Quarterly Reports on Form 10-Q for the quarters ended March 31, 2024 and June 30, 2024, originally filed with the SEC on April 30, 2024 and July 30, 2024, respectively (such reports, together with this Amendment, the “Amended Reports”). All material restatement information will be included in the Amended Reports, and the Company does not intend to separately amend other filings that were previously filed with the SEC.Accordingly, investors and other readers should rely only on the financial information and other disclosures regarding the periods described above in this Amendment and in any other future filings with the SEC (as applicable) and should not rely on any previously issued or filed reports, press releases, corporate presentations or similar communications relating to the Affected Periods.Background of CorrectionFollowing ongoing dialogue with the staff of the SEC, the Company concluded that it would amend the Form 10-K and Form 10-Qs for the first and second quarters of 2024 (collectively, the “Q1 and Q2 2024 Form 10-Qs”) to restate the segment information disclosure included in those filings. These restatements do not impact ADM’s Consolidated Statements of Earnings, Consolidated Statements of Comprehensive Income (Loss), Consolidated Balance Sheets, Consolidated Statements of Cash Flows or Consolidated Statements of Shareholders’ Equity as of and for the periods presented in the Amended Reports.As previously disclosed in Note 17. Segment and Geographic Information, to the Company’s Consolidated Financial Statements included in the Form 10-K, the Company identified and corrected certain intersegment sales amounts that either (i) were not in accordance with prior disclosures about presenting such sales at amounts approximating market or (ii) included intrasegment sales (resulting from sales within the segment) and should have included exclusively intersegment sales (resulting from sales from one segment to another). In connection with the error corrections, the Company identified a material weakness in its internal control over financial reporting related to its accounting practices and procedures for intersegment sales. The Company put in place a plan to remediate this material weakness, as disclosed in the Form 10-K and Q1 and Q2 2024 Form 10-Qs. In the course of testing new controls implemented as part of the Company’s material weakness remediation plan in the third quarter of 2024, the Company identified additional misclassified intersegment transactions. These newly identified errors concern additional intersegment sales for each of its Ag Services and Oilseeds, Carbohydrate Solutions and Nutrition segments that included certain intrasegment sales and should have included exclusively intersegment sales. The Company also identified some intersegment transactions between Ag Services and Oilseeds and Carbohydrate Solutions that were not accounted for consistently in accordance with revenue recognition and segment reporting standards and should not have been reported as intersegment sales. The Company also is correcting certain segment disclosure presentation errors in the Amended Reports.This Amendment reflects corrections for the newly identified errors related to intersegment sales (described below), the previously-corrected errors related to intersegment sales and segment operating profit, and other segment disclosure corrections (See Note 1 to the Consolidated Financial Statements in this Amendment for further information).Restatement of Consolidated Financial StatementsThis Amendment includes both audited restated Consolidated Financial Statements and unaudited restated consolidated financial information for the Affected Periods, as applicable. See Note 17 to the Consolidated Financial Statements in this Amendment for the restated audited segment information as of December 31, 2023 and 2022 and for the years ended December 31, 2023, 2022 and 2021. See Note 21 to the Consolidated Financial Statements in this Amendment for the unaudited restated segment information for each of the quarters within the years ended December 31, 2023 and 2022.Items Amended in This FilingThis Amendment amends and restates the following items of the Form 10-K:•Safe Harbor Statement•Part I - Item 1. Business•Part I - Item 1A. Risk Factors•Part II - Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations•Part II - Item 8. Financial Statements and Supplementary Data•Part II - Item 9A. Controls and Procedures•Part III - Item 10. Directors, Executive Officers and Corporate Governance•Part III - Item 11. Executive Compensation•Part IV - Item 15. Exhibits and Financial Statement SchedulesThe exhibit list included in Item 15, “Exhibits and Financial Statement Schedules” herein has been amended to contain currently dated certifications from the Company’s Chief Executive Officer (as Principal Executive Officer) and Chief Financial Officer (as Principal Financial Officer), as required by Sections 302 and 906 of the Sarbanes-Oxley Act of 2002 and filed as Exhibits 31.1/31.2 and 32.1/32.2, respectively, as well as an updated Consent of Independent Registered Public Accounting Firm filed as Exhibit 23.1.In accordance with applicable SEC rules, this Form 10-K/A also includes an updated signature page and Reports of Independent Registered Public Accounting Firm. Please note that the only changes to the Form 10-K are those related to the matters described herein and only in the Items listed above. Item 1A “Risk Factors” has been updated for the risk factor previously identified within the "Investigation Risks" related to the material weakness but that Item has not otherwise been updated to reflect developments occurring subsequent to the date of the Form 10-K. Otherwise, this Amendment speaks as of the original filing date of the Form 10-K, and does not modify, amend or update any other item or disclosures in the Form 10-K. As such, this Amendment does not reflect events occurring after the filing of the Form 10-K or modify or update those disclosures affected by subsequent events. Such subsequent information or events include, among others, the information and events described in our Quarterly Reports on Form 10-Q for the fiscal quarters ended March 31, 2024 and June 30, 2024, each of which we are restating currently with this Amendment, and the information and events described in our Current Reports on Form 8-K filed subsequent to the date of the Form 10-K. For a description of such subsequent information and events, please read our reports filed pursuant to the Exchange Act subsequent to the date of the Form 10-K, which update and supersede certain information contained in the Form 10-K and this Amendment.    
Common Stock [Member]      
Class of Stock [Line Items]      
Title of 12(b) Security Common Stock, no par value    
Trading Symbol ADM    
Security Exchange Name NYSE    
Debt Securities [Member]      
Class of Stock [Line Items]      
Title of 12(b) Security 1.000% Notes due 2025    
No Trading Symbol Flag true    
Security Exchange Name NYSE